Cargando…
Accelerating progress to innovation for patients: Trial design and risk stratification()
In early breast cancer, we integrate risk stratification and trial design, together with subtype, to focus on clinical questions in specific patient populations. In the past, trials enrolled an “all-comers,” broadly-defined population. More recently, trials enroll low-to intermediate-risk population...
Autor principal: | Regan, Meredith M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097804/ https://www.ncbi.nlm.nih.gov/pubmed/34836764 http://dx.doi.org/10.1016/j.breast.2021.11.010 |
Ejemplares similares
-
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020) -
Designing for Accelerated Translation (DART) of emerging innovations in health
por: Ramsey, Alex T., et al.
Publicado: (2019) -
Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
por: Kerkhof, Marjon, et al.
Publicado: (2007) -
Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
por: Romero, Jorge, et al.
Publicado: (2019) -
Accelerating innovation
Publicado: (2013)